These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30475986)

  • 1. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop.
    Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H
    Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2-SAMD2-SMAD3 Axis.
    Yang X; Xu C; Liu C; Wu X; Chen X; Hou J; Wang L
    Funct Integr Genomics; 2024 Jul; 24(4):123. PubMed ID: 38992207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
    Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
    Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
    Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
    Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis.
    Zu L; Xue Y; Wang J; Fu Y; Wang X; Xiao G; Hao M; Sun X; Wang Y; Fu G; Wang J
    Carcinogenesis; 2016 Mar; 37(3):333-343. PubMed ID: 26818357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
    Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
    Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
    Ge S; Zhang H; Deng T; Sun W; Ning T; Fan Q; Wang Y; Wang X; Zhang Q; Zhou Z; Yang H; Ying G; Ba Y
    Invest New Drugs; 2019 Oct; 37(5):923-934. PubMed ID: 30607520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
    Xiang Y; Zhang Y; Tang Y; Li Q
    Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1306 Mediates the Feedback Regulation of the TGF-β/SMAD Signaling Pathway in Granulosa Cells.
    Yang L; Du X; Liu L; Cao Q; Pan Z; Li Q
    Cells; 2019 Mar; 8(4):. PubMed ID: 30935128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 13. miR-122-5p negatively regulates the transforming growth factor-β/Smad signaling pathway in skeletal muscle myogenesis.
    Ding Z; Lin J; Sun Y; Cong S; Liu S; Zhang Y; Chen Q; Chen J
    Cell Biochem Funct; 2020 Mar; 38(2):231-238. PubMed ID: 31710120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling.
    Zhang K; Na T; Ge F; Yuan BZ
    Exp Cell Res; 2020 Jan; 386(2):111732. PubMed ID: 31770531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2.
    Li G; Wu F; Yang H; Deng X; Yuan Y
    Biomed Pharmacother; 2017 Dec; 96():1170-1178. PubMed ID: 29239816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.
    Yang S; Cho YJ; Jin L; Yuan G; Datta A; Buckhaults P; Datta PK
    Oncotarget; 2015 Oct; 6(32):33237-52. PubMed ID: 26356817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TGFBR2/SMAD2/DNMT1/miR-145 negative regulatory loop is responsible for LPS-induced sepsis.
    Ma F; Li Z; Cao J; Kong X; Gong G
    Biomed Pharmacother; 2019 Apr; 112():108626. PubMed ID: 30784922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer.
    Jafarian M; Hasannia T; Badameh P; Behmanesh M; Soltani BM
    Mol Biol Rep; 2024 Jun; 51(1):728. PubMed ID: 38861185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.
    Zhu N; Zhang XJ; Zou H; Zhang YY; Xia JW; Zhang P; Zhang YZ; Li J; Dong L; Wumaier G; Li SQ
    Acta Pharmacol Sin; 2021 Aug; 42(8):1280-1287. PubMed ID: 33536603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
    Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
    Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.